Coincident Linkage of Type 2 Diabetes, Metabolic Syndrome, and Measures of Cardiovascular Disease in a Genome Scan of the Diabetes Heart Study

Bowden, Donald W.; Rudock, Megan; Ziegler, Julie; Lehtinen, Allison B.; Xu, Jianzhao; Wagenknecht, Lynne E.; Herrington, David; Rich, Stephen S.; Freedman, Barry I.; Carr, J. Jeffrey; Langefeld, Carl D.
July 2006
Diabetes;Jul2006, Vol. 55 Issue 7, p1985
Academic Journal
Cardiovascular disease (CVD) is a major contributor to morbidity and mortality in type 2 diabetes, but the relationship between CVD and type 2 diabetes is not well understood. The Diabetes Heart Study is a study of type 2 diabetes-enriched families extensively phenotyped for measures of CVD, type 2 diabetes, and metabolic syndrome. A total of 977 Caucasian subjects from 358 pedigrees (575 type 2 diabetic relative pairs) with at least two individuals with type 2 diabetes and, where possible, unaffected siblings were included in a genome scan. Qualitative traits evaluated in this analysis are with or without the presence of coronary calcified plaque (CCP) and with or without carotid calcified plaque (CarCP) measured by electrocardiogram-gated helical computed tomography. In addition, prevalent CVD was measured using two definitions: CVD1, based on self-reported history of clinical CVD (393 subjects), and CVD2, defined as CVD1 and/or CCP >400 (606 subjects). These discrete traits (type 2 diabetes, metabolic syndrome, CVD1, CVD2, CCP, and CarCP) frequently coincide in the same individuals with concordance ranging from 42.9 to 99%. Multipoint nonparametric linkage analysis revealed evidence for coincident mapping of each trait (type 2 diabetes, metabolic syndrome, CVD1, CVD2, CCP, and CarCP) to three different genomic regions: a broad region on chromosome 3 (70-160 cM; logarithm of odds [LOD] scores ranging between 1.15 and 2.71), chromosome 4q31 (peak LOD 146 cM; LOD scores ranging between 0.90 and 2.41), and on chromosome 14p (peak LOD 23 cM; LOD scores ranging between 1.43 and 2.31). Ordered subset analysis (OSA) suggests that the linked chromosome 3 region consists of at least two separate loci on 3p and 3q. In addition, OSA based on lipid measures and other traits identify family subsets with significantly stronger evidence of linkage (e.g., CVD2 on chromosome 3 at 87 cM subsetting on low HDL with an initial LOD of 2.19 is maximized to an LOD of 7.04 in a subset of 25% of the families and CVD2 on chromosome 14 at 22 cM subsetting on high triglycerides with an initial LOD of 1.99 maximized to an LOD of 4.90 in 44% of the families). When subjects are defined as affected by the presence of each trait (type 2 diabetes, metabolic syndrome, CVD1, and CCP), significant evidence for linkage to the 3p locus is observed with a peak LOD of 4.13 at 87 cM. While the correlated nature of the traits makes it unclear whether these loci represent distinct type 2 diabetes, metabolic syndrome, or CVD loci or single loci with pleiotropic effects, the coincident linkage suggests that identification of the underlying genes may help clarify the relationship of diabetes, metabolic syndrome, and CVD. Diabetes 55:1985-1994, 2006


Related Articles

  • Cardiometabolic risk and educational level in adult patients with type 1 diabetes. Nádas, J.; Putz, Z.; Fövényi, J.; Gaál, Z.; Gyimesi, A.; Hídvégi, T.; Hosszúfalusi, N.; Neuwirth, G.; Oroszlán, T.; Pánczél, P.; Vándorfi, G.; Winkler, G.; Wittmann, I.; Jermendy, G. // Acta Diabetologica;Jun2009, Vol. 46 Issue 2, p159 

    A low educational level and a poor socioeconomic status could be associated with increased risk for chronic diseases. The aim of the study was to evaluate the relationship between the educational level and cardiometabolic risk in adult patients with type 1 diabetes ( n = 437; age: 38.0 ± 10.4...

  • Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes. Thorn, Lena M.; Forsblom, Carol; Wadén, Johan; Saraheimo, Markku; Tolonen, Nina; Hietala, Kustaa; Groop, Per-Henrik // Diabetes Care;May2009, Vol. 32 Issue 5, p950 

    OBJECTIVE -- To assess the predictive value of the metabolic syndrome in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS -- Patients were from the prospective Finnish Diabetic Nephropathy (FinnDiane) Study (n = 3,783): mean age 37 ± 12 years and diabetes duration 23 ± 12 years....


    Cardiovascular disease (CVD) is the leading cause of death and disability in the industrialized world, and the prevalence is increasing rapidly among developing nations. The rising prevalence of CVD worldwide may be attributed in large part to specific atherogenic changes in insulin resistance,...

  • From Diabetes to Metabolic Syndrome: A View Point on An Evolving Concept. Lim, Hoong S.; Lip, Gregory Y.H. // Current Pharmaceutical Design;Sep2007, Vol. 13 Issue 25, p2580 

    The current diagnostic threshold for diabetes mellitus is imposed on a continuous distribution of blood glucose measurement. A more clinical approach estimates a threshold above which the rate of diabetes-specific complications rises steeply. However, the diagnostic threshold for diabetes is...

  • Commentary: Metabolic syndrome and mortality. Farmer, Andrew // BMJ: British Medical Journal (International Edition);4/15/2006, Vol. 332 Issue 7546, p882 

    The article explores the clinical value of diagnosing metabolic syndrome. Originally metabolic syndrome referred to a grouping of risk factors for cardiovascular disease. The article discusses how the majority of people with metabolic syndrome have insulin resistance, the syndrome's possible...

  • Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. Wong, S. P. Y.; Huda, M.; English, P.; Bargiotta, A.; Wilding, J. P. H.; Johnson, A.; R. Corrall; Pinkney, J. H. // Diabetologia;Dec2005, Vol. 48 Issue 12, p2641 

    Aims/hypothesis: Familial partial lipodystrophy (FPLD) and obesity are both associated with increased risks of type 2 diabetes and cardiovascular disease. Although adipokines have been implicated, few data exist in subjects with FPLD; therefore we investigated a family with FPLD due to a lamin...

  • Diabetes and heart disease: a deadly duo.  // Australian Nursing Journal;May2006, Vol. 13 Issue 10, p39 

    The article reports on the susceptibility of diabetic patients to heart and cardiovascular diseases. Diabetes and heart diseases share the same risk factors such as obesity, high blood pressure and high cholesterol. Adults have at least one risk factor for heart disease according to a National...

  • Circulating Endothelial Progenitor Cells (EPCs) in Subjects with Impaired Glucose Regulation (Pre-Diabetes). Pucci, Laura; Lucchesi, Daniela; Iorio, Maria C.; Vanacore, Renato; di Stefano, Rosella; Fotino, Carmen; Triscornia, Stefano; Balberini, Alberto; Miccoli, Roberto; Penno, Giuseppe; del Prato, Stefano // Diabetes;Jun2007 Supplement 1, Vol. 56, pA194 

    Cumulative cardiovascular risk, and cardiovascular disease status alter number and function of circulating endothelial progenitor cells (EPCs). Furthermore, circulating EPCs levels predict cardiovascular events. Diabetes reduces circulating EPCs level. In this scenario, our purpose was to...

  • Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats. Chia Hui Apphia Eu; Wai Yen Alfred Lim; So Ha Ton; Kadir, Khalid bin Abdul // Lipids in Health & Disease;2010, Vol. 9, p81 

    Background: The metabolic syndrome, known also as the insulin resistance syndrome, refers to the clustering of several risk factors for atherosclerotic cardiovascular disease. Dyslipidaemia is a hallmark of the syndrome and is associated with a whole body reduction in the activity of lipoprotein...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics